Roskilde University

At Roskilde University, the Department of Hematology H60 supports a broad range of oncology and hematology trials focused on cancers such as acute myeloid leukemia, lymphoma, breast cancer, solid tumors, and glioblastoma. These studies are designed to test new treatment approaches, improve response monitoring, and evaluate how well emerging therapies work in people with difficult-to-treat disease.

• Studies in blood cancers and solid tumors aim to improve treatment effectiveness and long-term disease control
• Research includes lymphoma, leukemia, and advanced cancer types with limited treatment options
• Trials also explore better ways to measure treatment response and guide personalized care

This research area combines cancer treatment development with practical efforts to refine diagnosis and monitoring for patients.

A major focus at this site is cardiovascular disease research, including heart failure, atrial fibrillation, myocardial infarction, aortic valve stenosis, and atherosclerotic disease. The trials are aimed at improving prevention, reducing complications, and identifying better treatment strategies for people at risk of serious heart-related events.

• Research on heart failure examines ways to improve symptoms and reduce hospitalizations
• Studies in coronary disease and stroke prevention look at lowering major cardiovascular risks
• Several trials assess more personalized approaches to antithrombotic and heart failure care

These trials reflect a strong interest in practical therapies that may improve survival and daily functioning for patients with complex cardiovascular conditions.

The site also contributes to respiratory medicine through studies in chronic obstructive pulmonary disease, asthma, community-acquired pneumonia, and idiopathic pulmonary fibrosis. The purpose of this work is to evaluate new treatments, reduce flare-ups, and better understand how lung disease progresses in different patient groups.

• Trials in COPD and asthma focus on preventing exacerbations and improving day-to-day breathing control
• Research in pulmonary fibrosis and pneumonia explores treatment effectiveness and clinical recovery
• Some studies aim to improve outcomes for patients with complicated or treatment-resistant lung disease

Overall, this is an active field for testing therapies that may ease symptoms and reduce the burden of chronic lung illness.

A substantial part of the trial portfolio addresses immune system diseases, inflammatory disorders, and gastrointestinal disease, including Crohn’s disease, primary biliary cholangitis, idiopathic inflammatory myopathy, and calcinosis cutis. These studies aim to improve symptom control, support remission, and test whether new therapies can better manage chronic immune-related conditions.

• Research in Crohn’s disease focuses on improving disease control and treatment targets
• Trials in autoimmune and inflammatory disorders assess safety and effectiveness of newer therapies
• Work in liver and skin-related immune disease explores better ways to reduce disease activity

This area highlights a strong commitment to therapies that may help patients living with long-term inflammatory illness.

Roskilde University is also involved in studies of neurological disorders, rare diseases, and mental health, including amyotrophic lateral sclerosis, multiple system atrophy, migraine, postpartum depression, and inherited metabolic conditions such as phenylketonuria and Pompe disease. The aim is to test novel therapies, improve quality of life, and support better management of conditions that often have limited treatment options.

• Studies in neurology evaluate treatments for progressive disorders affecting movement and function
• Research in rare metabolic diseases looks at safer and more effective long-term management
• Mental health work includes efforts to prevent or reduce postpartum depression

This portfolio shows a clear interest in both high-need chronic diseases and uncommon conditions requiring specialized care.

Another important research theme involves diagnostic techniques, acute care, and treatment support across several specialties. Trials at the site examine approaches for stroke, critical illness, abdominal surgery, fractures, and other urgent conditions, with the goal of improving diagnosis, symptom relief, and clinical decision-making.

• Studies assess better ways to detect disease and monitor treatment response
• Acute care research looks at improving outcomes in emergency and intensive care settings
• Procedural studies focus on reducing pain, complications, and recovery time

These trials reflect a practical research focus on making everyday clinical care safer and more effective for patients across a wide range of conditions.